Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd.

ENLV · Nasdaq

Enlivex Therapeutics Ltd. (ENLV) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Enlivex Therapeutics Ltd. in 2026. The next earnings report is expected on August 24, 2026.

Earnings calendar

Next earnings date

24 Aug 2026

In 3 days

EPS estimate

-0.31

Revenue estimate

0

Past earnings

29 May 2026
EPS actual
-0.02 (0.0%)
estimate -0.02
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
25 Mar 2026
EPS actual
-0.09 (0.0%)
estimate -0.09
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
25 Feb 2026
EPS actual
-0.09 (0.0%)
estimate -0.09
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel
Exchange
Nasdaq
CEO
Oren Hershkovitz
Employees
71
IPO date
31 Jul 2014
ISIN
IL0011319527
Website
enlivex.com

Frequently asked questions

When does Enlivex Therapeutics Ltd. (ENLV) next report earnings?

Enlivex Therapeutics Ltd. (ENLV) is scheduled to report earnings on August 24, 2026.

What was Enlivex Therapeutics Ltd.'s most recent earnings date?

Enlivex Therapeutics Ltd. (ENLV) last reported earnings on May 29, 2026.

Where is Enlivex Therapeutics Ltd. stock listed?

Enlivex Therapeutics Ltd. (ENLV) is listed on Nasdaq.